Cas:150096-53-0 Dimethylbis(2-methyl-3H-benz[e]inden-3-yl)silane manufacturer & supplier

Chemical Name:Dimethylbis(2-methyl-3H-benz[e]inden-3-yl)silane

CAS.NO:150096-53-0

Synonyms:EthanaMiniuM,2-hydroxy-N-(2-hydroxyethyl)-N,N-diMethyl-,chloride;dimethylbis(2-methylbenzo[e]indenyl)silane;dimethylbis(2-methyl-4,5-benzo-indenyl)silane;dimethylsilylbis(2-methylbenzindenyl);BIS(2-HYDROXYETHYL)DIMETHYLAMMONIUMCHLORIDE;2-hydroxy-n-(2-hydroxyethyl)-n,n-dimethyl-ethanaminiuchloride;Dimethyl-bis-(2-hydroxy-aethyl)-ammoniumchlorid;(CH3)2Si(2-methyl-benz[e]indenyl)2;DIMETHYLDIETHANOLAMMONIUM CHLORIDE;bis(2-methyl-4,5-benzoindenyl) dimethylsilane

Molecular Formula:C₃₀H₂₈Si

Molecular Weight:416.62900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:594.4ºC at 760 mmHg

Density:1.14

Index of Refraction:1.675

PSA:

Exact Mass:416.19600

LogP:8.67200

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like EthanaMiniuM,2-hydroxy-N-(2-hydroxyethyl)-N,N-diMethyl-,chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,bis(2-methyl-4,5-benzoindenyl) dimethylsilane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-hydroxy-n-(2-hydroxyethyl)-n,n-dimethyl-ethanaminiuchloride Use and application,EthanaMiniuM,2-hydroxy-N-(2-hydroxyethyl)-N,N-diMethyl-,chloride technical grade,usp/ep/jp grade.

Related News: After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. Transcription factor (human clone 13/R14898 gene SUPT5H reduced) manufacturers For Franco Stevanato, tapping public markets will give the company the freedom to keep innovating as it enters the next chapter of its 70-plus-year history. Eupatoriopicrin suppliers Biogen’s top research chief, Dr. Al Sandrock, defended the drug in an open letter released alongside the company’s earnings Thursday, saying its approval has been subject to “extensive misinformation and misunderstanding.” 6-ethoxy-1,3,5-trimethyl-1H-pyrimidine-2,4-dione vendor & factory.